Stocksigma LogoStocksigma Logo

Glenmark Pharmaceuticals Schedules Q2 FY27 Earnings Call for November 2026

Glenmark Pharmaceuticals Limited has scheduled its earnings conference call on 6th Nov'26 from 8:30 am to 9:30 am IST to discuss the unaudited financial

Glenmark Pharmaceuticals Schedules Q2 FY27 Earnings Call for November 2026

Glenmark Pharmaceuticals Ltd 路 Intimation 路 06 Nov 2026, 8:30 am

Glenmark Pharmaceuticals Schedules Q2 FY27 Earnings Call for November 2026 Glenmark Pharmaceuticals Limited has scheduled its earnings conference call on 6th Nov'26 from 8:30 am to 9:30 am IST to discuss the unaudited financial results for the quarter ended 30th Sep'26 (Q2 FY27). Universal dial-in numbers include +91 22 6280 1298 and +91 22 7115 8199, alongside international toll-free access for the USA, UK, Singapore, and Hong Kong.

Original exchange filing (PDF)

More announcements from Glenmark Pharmaceuticals Ltd

All Glenmark Pharmaceuticals Ltd announcements